Showing results (111-120 of 272) with videos related to

Sort By:
Pageof 28
The Journal of Biological Chemistry|October 21, 2023
NOTCH2 sensitizes the chondrocyte to the inflammatory response of tumor necrosis factor αErnesto Canalis, Jungeun Yu, Vijender Singh, et al.
Clinics (Sao Paulo, Brazil)|January 19, 2011
Glucocorticoid-induced osteoporosis in rheumatic diseasesRosa Maria Rodrigues Pereira, Jozélio Freire de Carvalho, Ernesto Canalis
The Journal of Biological Chemistry|January 13, 2006
Notch 1 overexpression inhibits osteoblastogenesis by suppressing Wnt/beta-catenin but not bone morphogenetic protein signalingValerie Deregowski, Elisabetta Gazzerro, Leah Priest, et al.
Bone|November 21, 2024
A NOTCH2 pathogenic variant and HES1 regulate osteoclastogenesis in induced pluripotent stem cellsErnesto Canalis, Lauren Schilling, Emily Denker, et al.
Plos One|March 18, 2015
Cyclooxygenase-2 suppresses the anabolic response to PTH infusion in miceShilpa Choudhary, Ernesto Canalis, Thomas Estus, et al.
The Journal of Biological Chemistry|March 28, 2021
Activation of Notch3 in osteoblasts/osteocytes causes compartment-specific changes in bone remodelingErnesto Canalis, Stefano Zanotti, Lauren Schilling, et al.
Endocrine|April 3, 2020
Morphometric vertebral fractures in patients with castration-resistant prostate cancer undergoing treatment with radium-223: a longitudinal study in the real-life clinical practiceGherardo Mazziotti, Marcello Rodari, Fabrizia Gelardi, et al.
European Endocrinology|June 7, 2018
Osteoporosis in Human Immunodeficiency Virus Patients - An Emerging Clinical ConcernFilippo Maffezzoni, Teresa Porcelli, Ioannis Karamouzis, et al.
Plos One|May 10, 2022
Use of antisense oligonucleotides to target Notch3 in skeletal cellsErnesto Canalis, Michele Carrer, Tabitha Eller, et al.
Bone|June 17, 2009
Vertebral fractures in males with type 2 diabetes treated with rosiglitazoneTatiana Mancini, Gherardo Mazziotti, Mauro Doga, et al.
Pageof 28